Cargando…

Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project

Background: The Base of the Pyramid (BoP) project is a public–private partnership initiated by Novo Nordisk that aims to facilitate access to diabetes care for people at the base of the economic pyramid in low- and middle-income countries (LMICs). In Kenya, the BoP, through a partnership model, aims...

Descripción completa

Detalles Bibliográficos
Autores principales: Shannon, Geordan D., Haghparast-Bidgoli, Hassan, Chelagat, Winnie, Kibachio, Joseph, Skordis-Worrall, Jolene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534215/
https://www.ncbi.nlm.nih.gov/pubmed/31116677
http://dx.doi.org/10.1080/16549716.2019.1605704
_version_ 1783421364368048128
author Shannon, Geordan D.
Haghparast-Bidgoli, Hassan
Chelagat, Winnie
Kibachio, Joseph
Skordis-Worrall, Jolene
author_facet Shannon, Geordan D.
Haghparast-Bidgoli, Hassan
Chelagat, Winnie
Kibachio, Joseph
Skordis-Worrall, Jolene
author_sort Shannon, Geordan D.
collection PubMed
description Background: The Base of the Pyramid (BoP) project is a public–private partnership initiated by Novo Nordisk that aims to facilitate access to diabetes care for people at the base of the economic pyramid in low- and middle-income countries (LMICs). In Kenya, the BoP, through a partnership model, aims to strengthen five pillars of diabetes care: increased awareness of diabetes; early diagnosis of diabetes; access to quality care by trained professionals; stable and affordable insulin supply; and improved self-management through patient education. Objectives: This study evaluates the extent to which BoP Kenya is scalable and sustainable, whether stakeholders share in its value, and whether BoP Kenya has improved access to diabetes care. Method: The Rapid Assessment Protocol for Insulin Access (RAPIA), an approach developed to provide a broad situational analysis of diabetes care, was used to examine health infrastructure and diabetes care pathways in Kenya. At the national level, the RAPIA was applied in a SWOT analysis of the BoP through in-depth interviews with key stakeholders. At individual and county health system levels, RAPIA was adapted to explore the impact of the BoP on access to diabetes care through a comparison of an intervention and control county. Results: The BoP was implemented in 28 of 47 counties in Kenya. Meru, a county where BoP was implemented, had 35 of 62 facilities (56%) participating in the BoP. Of the five pillars of the BoP, most notable progress was made in achieving the fourth (stable and affordable insulin supply). A price ceiling of 500KSh (US$5) per vial of insulin was established in the intervention county, with greater fluctuation and stock-outs in the non-intervention county. Despite reduced insulin costs, many patients with diabetes could not afford the additive expenses of monitoring, medicines, and travel. Less progress was made over the other pillars, which also faced challenges to sustainability and scalability. Conclusion: In the context of the rising prevalence of non-communicable diseases in LMICs, cross-sector approaches to improving access to care are increasingly needed. Public–private partnerships such as the BoP are necessary but not sufficient to ensure access to health care for people with diabetes at the base of the economic pyramid in Kenya.
format Online
Article
Text
id pubmed-6534215
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-65342152019-05-31 Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project Shannon, Geordan D. Haghparast-Bidgoli, Hassan Chelagat, Winnie Kibachio, Joseph Skordis-Worrall, Jolene Glob Health Action Original Article Background: The Base of the Pyramid (BoP) project is a public–private partnership initiated by Novo Nordisk that aims to facilitate access to diabetes care for people at the base of the economic pyramid in low- and middle-income countries (LMICs). In Kenya, the BoP, through a partnership model, aims to strengthen five pillars of diabetes care: increased awareness of diabetes; early diagnosis of diabetes; access to quality care by trained professionals; stable and affordable insulin supply; and improved self-management through patient education. Objectives: This study evaluates the extent to which BoP Kenya is scalable and sustainable, whether stakeholders share in its value, and whether BoP Kenya has improved access to diabetes care. Method: The Rapid Assessment Protocol for Insulin Access (RAPIA), an approach developed to provide a broad situational analysis of diabetes care, was used to examine health infrastructure and diabetes care pathways in Kenya. At the national level, the RAPIA was applied in a SWOT analysis of the BoP through in-depth interviews with key stakeholders. At individual and county health system levels, RAPIA was adapted to explore the impact of the BoP on access to diabetes care through a comparison of an intervention and control county. Results: The BoP was implemented in 28 of 47 counties in Kenya. Meru, a county where BoP was implemented, had 35 of 62 facilities (56%) participating in the BoP. Of the five pillars of the BoP, most notable progress was made in achieving the fourth (stable and affordable insulin supply). A price ceiling of 500KSh (US$5) per vial of insulin was established in the intervention county, with greater fluctuation and stock-outs in the non-intervention county. Despite reduced insulin costs, many patients with diabetes could not afford the additive expenses of monitoring, medicines, and travel. Less progress was made over the other pillars, which also faced challenges to sustainability and scalability. Conclusion: In the context of the rising prevalence of non-communicable diseases in LMICs, cross-sector approaches to improving access to care are increasingly needed. Public–private partnerships such as the BoP are necessary but not sufficient to ensure access to health care for people with diabetes at the base of the economic pyramid in Kenya. Taylor & Francis 2019-05-22 /pmc/articles/PMC6534215/ /pubmed/31116677 http://dx.doi.org/10.1080/16549716.2019.1605704 Text en © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Shannon, Geordan D.
Haghparast-Bidgoli, Hassan
Chelagat, Winnie
Kibachio, Joseph
Skordis-Worrall, Jolene
Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project
title Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project
title_full Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project
title_fullStr Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project
title_full_unstemmed Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project
title_short Innovating to increase access to diabetes care in Kenya: an evaluation of Novo Nordisk’s base of the pyramid project
title_sort innovating to increase access to diabetes care in kenya: an evaluation of novo nordisk’s base of the pyramid project
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6534215/
https://www.ncbi.nlm.nih.gov/pubmed/31116677
http://dx.doi.org/10.1080/16549716.2019.1605704
work_keys_str_mv AT shannongeordand innovatingtoincreaseaccesstodiabetescareinkenyaanevaluationofnovonordisksbaseofthepyramidproject
AT haghparastbidgolihassan innovatingtoincreaseaccesstodiabetescareinkenyaanevaluationofnovonordisksbaseofthepyramidproject
AT chelagatwinnie innovatingtoincreaseaccesstodiabetescareinkenyaanevaluationofnovonordisksbaseofthepyramidproject
AT kibachiojoseph innovatingtoincreaseaccesstodiabetescareinkenyaanevaluationofnovonordisksbaseofthepyramidproject
AT skordisworralljolene innovatingtoincreaseaccesstodiabetescareinkenyaanevaluationofnovonordisksbaseofthepyramidproject